Bad genes, good people, association, linkage, longevity and the prevention of cardiovascular disease

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 7, 1999, Pages 576-579

  Luft, Friedrich C ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Ageing; Angiotensin converting enzyme; Heart rate variability; Insertion deletion polymorphism; Longevity; Molecular genetics

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEART SIZE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; FEMALE; GENOTYPE; HUMANS; LINKAGE (GENETICS); LONGEVITY; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0033065369     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03080.x     Document Type: Conference Paper

References (22)

1. 1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997; 349: 1269-76.
2. 2. Charlesworth B, Partridge L. Ageing: Levelling of the grim reaper. Curr. Biol. 1997; 7: R440-2.
3. 3. Agerholm-Larsen B,Tybjaerg-Hansen A, Frikke-Schmidt R, Groønholdt MLM, Jensen G, Nordestgaard BG. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann. Intern. Med. 1997; 127: 346-55.
4. 4. Busjahn A, Knoblauch J, Knoblauch M et al. Angiotensin converting enzyme and angiotensinogen gene polymorphisms, plasma levels, and left ventricular size: A twin study. Hypertension 1997; 29: 165-70.
5. 5. Busjahn A, Voss A, Knoblauch H et al. Angiotensin converting enzyme and angiotensinogen gene polymorphisms and heart rate variability: A twin study. Am. J Cardiol. 1998; 81: 755-60.
6. 6. Busjahn A, Faulhaber H-D, Viken RJ, Rose RJ, Luft FC. Genetic influences on blood pressure with the cold pressor lest: A twin study. J. Hypertens 1996; 14: 1195-9.
7. 7. Baltes PB, Mayer KU, Elwert G et al. AG Altern und Gesellschaftliche Entwicklung (AGE). Berlin-Brandenburgische Akademie der Wissenschaften, Akademie Verlag, Berlin. 1995; 327-62.
8. 8. Hegele RA, Young TK, Connelly PW. (1997) Are Canadian Inuit at increased genetic risk for coronary heart disease? J. Mol Med. 1997; 75: 364-70.
9. 9. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting-enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359; 641-4.
10. 10. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 1995; 332: 706-11.
11. 11. Schunkert H, Hense H-W, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 1994; 330: 1634-8.
12. 12. Lindpaintner K, Lee M, Larson MG et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N. Engl. J. Med. 1996; 334: 1023-8.
13. 13. Weiss EJ, Bray PF, Tayback M et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 1996; 334: 1090-4.
14. 14. Ridker PM, Hennekens CH, Schmitz C et al. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-8.
15. 15. Schork NJ. Genetically complex cardiovascular traits: Origins, problems, and potential solutions. Hypertension 1997; 29: 145-9.
16. 16. Wright S. The shifting balance of evolution theory and macroevolution. Annu. Rev. Genet. 1982; 16: 1-19.
17. 17. Greenberg DA. Linkage analysis of 'necessary' disease loci versus susceptibility' loci. Am. J. Hum. Genet. 1992; 52: 135-43.
18. 18. Medawar PB. An Unsolved Problem in Biology. HK Lewis, London. 1952.
19. 19. Thatcher AR, Kannisto V, Vaupel JW, Yashin AL. The Force of Mortality from Age 80-120. University Press, Odense, Denmark. 1996.
20. 20. Abrams PA, Ludwig D. Optimality theory, Gompertz' law, and the disposable soma theory of senescence. Evolution 1995; 49: 1055-66.
21. 21. Mueller LD, Rose MR. Evolutionary theory predicts late-life mortality plateaus. Proc. Natl Acad. Sci. USA 1996; 93: 15249-53.
22. 22. Kirkwood TB, Holliday R. Evolution of ageing and longevity. Proc. Roy. Soc. Lond (Biol.) 1979; 205: 531-46.